CERVICAL CYTOLOGY MANAGEMENT GUIDELINES CAMTASIA Flashcards
Pap smear
Pap is screening tool
Tissue sample is diagnose
TERMINOLOGY REVIEW: Specimen Adequacy
- Satisfactory for evaluation OR unsatisfactory for evaluation ** need lots of squamous cells to be satisfactory specimen ***
- If adequate squamous cells, will comment on presence/absence of an endocervical/transformation zone component of endocervical or squamous metaplastic cells
The transformation zone
The transformation zone is where ectocervix meet endocervix , endocervix meet ectocervix
**now that you two have been introduced, we can have squamous metaplasia but hopefully not cervical cancer !!!!
Post-menstural & pregnant women don’t have the endocervical component !!!
TERMINOLOGY REVIEW: interpretation/result
NORMAL FINDINGS
- negative for intraepithelial lesion or malignancy = GOOD NEWS !!!
- report may include comment about organisms present (trichomonas, candida, ect.)
- report may include comment about other non-neoplastic findings (atrophy, inflammatory cellular changes, IUD-associated change, ect)
- you may or may not decide to evaluate further or tx these additional criteria depending on the patient situation
TERMINOLOGY REVIEW: abnormal cells
one type of epithelial cell abnormality is :
→Atypical squamous cells (ASC) divided further into :
(1) Atypical cells of undetermined significance (ASC-US) – cellular abnormalities that were more marked than those attributable to reactive changes but that quantitatively or qualitatively fell short of a definitive dx of squamous intraepithelial lesion (SIL) —- may be normal but need to keep eye on thing…
(2) Atypical squamous cells, cannot exclude high grade lesion (ASC-H) : positive predictive value for CIN 2 or 3 (moderate or severe dysplasia)
ASC-US not same as ASC-H
potential serious ladder past ASC are
- low-grade squamous intraepithelial lesion (LSIL)- includes mild dysplasia, cervical intraepithelial neoplasia (CIN) 1
- high-grade squamous intraepithelial lesion (HSIL)- includes moderate and severe dysplasia, carcinoma in situ, CIN 2 and CIN 3
HPV (HUMAN PAPILLOMAVIRUS)
- necessary for development of cervical cancer
- almost exclusively acquired through sexual exposure
- there are many many strains ~40 strains
- infect the genital tract:
- high risk (HR) HPV: ~12 Strains known to be cancer-causing
- low risk HPV: not thought to be cancer causing (but can cause genital warts, for example)
- anyone can have >1 strain
- HPV infection comes & goes- can be cleared by immune system
In 2009, ASCCP published another management option for women age 30 & older who have negative PAP and positive HPV:
For women age 30 and older can be helpful to know which HR type of HPV it is ….
→women with negative PAP but positive HPV types 16 & 18 = COLPO NOW
→Women with negative PaP but positive HPV other than types 16 & 18 : repeat both tests in 12 months.
For women age 30 & older …it matters which type of high risk HPV they have !!!
**in other words, HPV types 16 & 18 are not only HIGH RISK, they are HIGH HIGH RISK !!!!
WHEN DO WE TEST FOR HPV?
• we only ever test for HIGH risk HPV types
• We DO test for HPV in these situation:
- routine co-testing (with a Pap) in women 30 and over
- triage women age 21 & over with ASC-US Paps
- triage of women age 25 & over with LSIL Paps
• We DO NOT test for HPV in these situations:
screening before HPV vaccination
- routine co-testing in women less than age 30
- investigation of genital warts or other STIs
HOW OFTEN SHOULD WOMEN HAVE A PAP?
Adolescents (20 y.o and younger)
DO NOT SCREEN = NO PAP
Regardless of age @ first sexual intercourse
Regardless of risk factors.
HOW OFTEN SHOULD WOMEN HAVE A PAP?
Women 21-29 y.o
Pap ever 3 years
DO NOT routinely test for HPV
how often should women have a pap?
Women age 30-65
Pap (w/o HPV) every 3 years (preferred by USPSTF) OR Pap (w/ HPV) every 5 years (preferred by ACS/ASCCP/ASCP)
HOW OFTEN SHOULD WOMEN HAVE A PAP?
women more than age 65
No more Paps for women with adequate prior screening and not otherwise at high risk for cervical cancer ( USPSTF)
No more Paps for women with adequate prior screening, no hx of CIN 2 or 3. Do not resume screening even if new partner (ACS/ASCCP/ASCP)
Exclusions (women who need more frequent Paps)
- immunocompromised HIV
- Diethylstilbestrol (DES) daughters
- Hx of cervical cancer or CIN 2 or 3